Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

Recent & Breaking News (TSXV:CZO)

Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting

GlobeNewswire June 5, 2019

Ceapro Inc. Commences Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent

GlobeNewswire June 3, 2019

Ceapro Inc. Reports 2019 First Quarter Financial Results and Highlights

GlobeNewswire May 23, 2019

Ceapro Inc. Announces Receipt of Site License from Health Canada

GlobeNewswire May 15, 2019

Ceapro Inc. to Present at the ThinkEquity Conference in New York City

GlobeNewswire April 24, 2019

Ceapro Inc. Announces Positive Key Findings from Three Oral Presentations Given at European Meeting on Supercritical Fluids

GlobeNewswire April 15, 2019

Ceapro Inc. Reports Fourth Quarter and Full Year 2018 Results and Highlights

GlobeNewswire April 11, 2019

Ceapro Announces Acceptance of Abstract for Presentation at the 2019 American College of Sports Medicine Annual Meeting

GlobeNewswire March 27, 2019

Ceapro Inc. Announces Issuance of Indian Patent Application for Enabling Pressurized Gas eXpanded (PGX) Technology

GlobeNewswire March 25, 2019

Ceapro Inc. Announces Three Abstracts Selected for Oral Presentation at the 17th European Meeting on Supercritical Fluids (EMSF 2019)

GlobeNewswire February 26, 2019

Ceapro Announces 2019 Management Team and Grant of Stock Options and Restricted Share Units

GlobeNewswire January 7, 2019

Ceapro Inc. to Present at Biotech Showcase™ 2019

GlobeNewswire January 2, 2019

Ceapro Inc. Presents PGX Technology at the Society of Cosmetic Chemists’ 72nd Annual Scientific Meeting and Technology Showcase

GlobeNewswire December 12, 2018

Ceapro Inc. Reports 2018 Third Quarter and Nine-Month Financial Results and Operational Highlights

GlobeNewswire November 21, 2018

Ceapro Inc. Announces Completion of Successful Audits by Major Customers

GlobeNewswire November 19, 2018

Ceapro Inc. Receives the 2018 Award for Most Innovative Raw Material at Cosmetics 360 Salon in Paris

GlobeNewswire October 23, 2018

Ceapro Inc. Receives Approval from Health Canada to Commence Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent

GlobeNewswire October 9, 2018

Ceapro Inc. Reports 2018 Second Quarter and Six-Month Financial Results and Operational Highlights

GlobeNewswire August 28, 2018

Ceapro Inc. Settles Judgements in AVAC Ltd. Actions

GlobeNewswire August 27, 2018

Ceapro Inc. Announces Publication of Positive Data from Functional Beverage Formulation Study in Journal of Functional Foods

GlobeNewswire June 27, 2018